Skip to main content

Month: September 2021

Global Powersports leader selects TrackX as its company-wide vehicle inventory management solution

TrackX becomes central source for vehicle inventory information TrackX Control Tower leveraged for reporting and analytics Integration with multiple operational systems Vehicles are tracked via GPS tags Driving logistics savings and delivery efficienciesDENVER, Sept. 20, 2021 (GLOBE NEWSWIRE) — TrackX Holdings Inc. (TSXV:TKX), (OTC:TKXHF), (FSE:3TH) (“TrackX” or the “Company), a leading provider of real-time end-to-end asset tracing, tracking and collaboration solutions announced today that global powersports leader, Polaris Inc., has selected the Company’s technology platform as its corporate vehicle inventory system of record. This announcement represents a significant expansion of the two companies’ long-standing partnership and demonstrates the return on investment that TrackX, a fully integrated hardware and cloud-based...

Continue reading

Immunocore presents data at the European Society for Medical Oncology (ESMO) Congress 2021 demonstrating a reduction in circulating tumor DNA (ctDNA) while on tebentafusp is associated with overall survival in the Phase 2 clinical trial

PRESS RELEASE Immunocore presents data at the European Society for Medical Oncology (ESMO) Congress 2021 demonstrating a reduction in circulating tumor DNA (ctDNA) while on tebentafusp is associated with overall survival in the Phase 2 clinical trial Linear correlation between the magnitude of ctDNA reduction on tebentafusp and improved overall survival 70% of evaluable patients had any ctDNA reduction and 14% had ctDNA clearance (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US (20 September 2021) Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, presented new data from the Company’s lead program,...

Continue reading

Eden Empire Announces Joint Venture for Flagship Location

EDEN Cannabis Announces Flagship LocationVANCOUVER, British Columbia, Sept. 20, 2021 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “EDENTM” or “Eden Empire”) is thrilled to announce that it has entered into a share purchase agreement with a private arm’s length third party (the “Buyer”) to sell a 50% interest in its proposed Davie Street location for proceeds of $1,050,000CAD in cash. Following the closing date of the transaction, EDENTM will continue to operate the Davie Street location through a joint venture vehicle with the Buyer and it is expected that associated costs will be shared. Key Location Takeaways:Sits on the 1600 Block of Davie Street of Vancouver’s West End which is well-anchored with a new supermarket, drugstore, liquor store and soon-to-be cannabis...

Continue reading

Bunker Hill Announces Updated PEA: 42% Increase in NPV to $143M, 29% Decrease in AISC, 41% Increase in FCF Over Extended 11 Year Mine Life

Bunker Hill to Host a Webinar on Tuesday, September 21 @ 11:00am ET / 8:00am PT HIGHLIGHTS:Materially improved financial returns: 143M NPV (+42% increase), 35% IRR, 2.6 year payback, $25M annual average FCF (+28% increase) at $1.15/lb Zn, $0.90/lb Pb, $20/oz Ag (metal prices unchanged from April 2021 PEA) Increased use of Long-Hole Open Stoping mining drives a 29% reduction in AISC to $0.47 per pound of payable zinc Nearly 1 billion zinc equivalent pounds (including over 8 million ounces of silver) produced over an extended 11 year mine life.  The mine’s significant high-grade silver potential outside the current resource is not included CEO Sam Ash and CFO David Wiens to host live interactive 6ix virtual investor event on Tuesday, September 21st at 11:00AM ET / 8:00AM PT.  Investors are invited to register for this event at: [LINK] TORONTO,...

Continue reading

Avalo to Present at the 2021 Cantor Virtual Global Healthcare Conference

WAYNE, Pa. and ROCKVILLE, Md., Sept. 20, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases announced today that members of its senior management team will present in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference being held from September 27th through September 30th, 2021. 2021 Cantor Virtual Global Healthcare ConferenceDate: Wednesday, September 29th, 2021Time: 2:00 PM ET A live webcast of the fireside chat can be accessed under the “News/Events” page in the Investors section of the Company’s website at www.avalotherapeutics.com. About Avalo Therapeutics Avalo...

Continue reading

Yooma Wellness to Acquire Sparkling Water Brand Big Swig, Inc.

The acquisition of Big Swig’s sparkling water beverage business will add to the scope of Yooma’s brands and presence in the United States and create the opportunity for innovative new product offerings. TORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma“) (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has entered into definitive agreements to complete the acquisition of Big Swig, Inc. (“Big Swig”), a U.S. based seller of sparkling water beverages. The acquisition will increase Yooma’s presence in retailers located throughout the southern United States and add the Big Swig and Hard Swig brands to Yooma’s expanding portfolio, with opportunities for the creation of exciting new...

Continue reading

Form 8.3 – [Safestay plc – 17 09 2021 – Opening Declaration] – (HHL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: HARGREAVE HALE LIMITED(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SAFESTAY PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing undertaken:        For an opening...

Continue reading

Bridge Specialty Group, LLC announces the asset acquisition of Gremesco of New Jersey, LLC

DAYTONA BEACH, Fla., Sept. 20, 2021 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and Joseph V. Certo and Christopher M. Larson, the owners of Gremesco of New Jersey, LLC, today announced that a Bridge Specialty Group company and subsidiary of Brown & Brown, Inc. has acquired substantially all of the assets of Gremesco of New Jersey. Gremesco of New Jersey is a wholesale insurance broker and was founded in 2000. The firm offers property and casualty insurance products and services through retail agents primarily in New Jersey and New York. Following the transaction, the Gremesco of New Jersey operations will become part of Bridge Specialty Group’s “Morstan General Agency” office (Morstan). The combined operations will do business from Morstan’s Woodbridge, New Jersey...

Continue reading

Annexon Biosciences to Highlight Neurodegeneration Franchise in Upcoming Virtual C1q Series R&D Event

CAMBRIDGE, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain and eye, today announced that the company will host its second virtual C1q Series event on Monday, September 27, 2021, at 10:00 a.m. ET, to discuss its neurodegeneration franchise. Annexon’s R&D event will include presentations from the executive team as well as prominent key opinion leaders. A live webcast and slide presentation will be available in the “Events and Presentations” page of the “Investors” section of annexonbio.com. To register for this event, please access the online registration link here. About Annexon Annexon...

Continue reading

Red Pine Continues to Intersect High-Grade Gold in the Jubilee Shear Zone; 25.73 g/t gold over 4.78 metres (true width – “TW”) including 41.73 g/t gold over 1.93 metres (TW)

Figure 12021 Drill Holes CompletedFigure 2Cross Section of the Jubilee South DrillingFigure 3Drill Holes at Southern Extension of Surluga ResourceFigure 4Drill Holes at Northern Extension of Surluga ResourceTORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) is pleased to report new and notable results from its 2021 drilling program at the Wawa Gold Project, including the discovery of high-grade gold mineralization in the Jubilee Shear Zone more than 400 metres down-dip of the current boundary of the Surluga Deposit inferred resource. Highlights of the 2021 Drilling Program (Tables 1 and 2, Figures 1 and 2)Intersection in SD-21-298A of 25.73 g/t gold over 4.78 metres true width (TW) in the Jubilee Shear...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.